ImmuPharma PLC (IMM)
LSE
3.41
+0.0050 (+0.15%)
Closed
Aug 25, 2026
Day's Range
3.403.98
52 wk Range
1.5019.40
Financial Statements - IMM - ImmuPharma PLC
Revenue
0
Net Income
-1.80M▲ 27.2%
EBITDA
-2.49M▼ 6.3%
Free Cash Flow
-2.37M▼ 34.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 118.35K | 126.66K |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -2.53M | -2.27M | -3.06M | -3.02M | -5.15M | -5.58M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -2.17M | -2.77M | -3.41M | -4.45M | -8.94M | -7.24M |
| Income Tax | -364.49K | -295.87K | -497.10K | -648.90K | -766.81K | -386.24K |
| Net Income | -1.80M | -2.48M | -2.92M | -3.80M | -8.17M | -6.85M |
| EPS Basic | - | -0.006 | -0.0081 | -0.0126 | -0.0325 | -0.0343 |
| EPS Diluted | - | -0.006 | -0.0081 | -0.0126 | -0.0325 | -0.0343 |
| Basic Shares Outstanding | - | 416.43M | 362M | 302.91M | 251.16M | 200.17M |
| Diluted Shares Outstanding | - | 416.43M | 362M | 302.91M | 251.16M | 200.17M |
| Ebit | -2.16M | -2.77M | -3.41M | -4.45M | -8.81M | -7.01M |
| Ebitda | -2.49M | -2.34M | -3.02M | -3.11M | -5.12M | -5.72M |
| Net Income Continuous Operations | 1.80M | -2.48M | -2.92M | -3.02M | -6.58M | -5.58M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
